Comparative study of quality of life between endometriosis patients receiving GnRH agonist and dienogest therapy: A cross-sectional study using Endometriosis Health Profile-30 (EHP-30)
Narra J · 25.06.2026 · 6 (2) · e3097
DOI: 10.52225/narra.v6i2.3097 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Narra J, online erschienen am 25.06.2026. Verfasst von Iqbal A Pravasta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. Hauptthemen laut MEDLINE: Nandrolone, Endometriosis, Quality of Life, Gonadotropin-Releasing Hormone. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Endometriosis is a chronic gynecological disease that substantially impairs quality of life. Gonadotropin-releasing hormone (GnRH) agonists and dienogest are commonly used hormonal therapies for endometriosis; however, direct comparisons of their effects on quality of life remain limited. This study aimed to compare quality of life between patients with endometriosis receiving GnRH agonist and dienogest therapy using the Endometriosis Health Profile-30 (EHP-30). A comparative cross-sectional study was conducted among 100 patients with endometriosis at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia, comprising 50 patients receiving GnRH agonist therapy and 50 receiving dienogest therapy. Quality of life was assessed using the Indonesian version of the EHP-30, with higher scores indicating poorer quality of life. Between-group comparisons and multiple linear regression were performed. Patients receiving dienogest had significantly lower total EHP-30 scores than those receiving GnRH agonist therapy (20.1±9.6 vs 43.7±14.9; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
- Department of Obstetrics and Gynecology, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia.
Zitieren
APA
Pravasta, I. A., Rajuddin, R., Yeni, C. M., Rusly, D. K., & Utami, N. A. (2026). Comparative study of quality of life between endometriosis patients receiving GnRH agonist and dienogest therapy: A cross-sectional study using Endometriosis Health Profile-30 (EHP-30). Narra J, 6(2), e3097. https://doi.org/10.52225/narra.v6i2.3097
Vancouver
Pravasta IA, Rajuddin R, Yeni CM, Rusly DK, Utami NA. Comparative study of quality of life between endometriosis patients receiving GnRH agonist and dienogest therapy: A cross-sectional study using Endometriosis Health Profile-30 (EHP-30). Narra J. 2026;6(2):e3097. doi:10.52225/narra.v6i2.3097
BibTeX
@article{Pravasta2026,
author = {Pravasta, Iqbal A and Rajuddin, Rajuddin and Yeni, Cut M and Rusly, Dewi K and Utami, Niken A},
title = {Comparative study of quality of life between endometriosis patients receiving GnRH agonist and dienogest therapy: A cross-sectional study using Endometriosis Health Profile-30 (EHP-30)},
journal = {Narra J},
year = {2026},
volume = {6},
number = {2},
pages = {e3097},
doi = {10.52225/narra.v6i2.3097}
}
EUVIMED